Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

20. Mai 2012

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Dienstleistungen Partner

Links

Schrift:

Seite 1 von 702


	Artikel 1 - 20 / 14034

	Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. Romaguera D, Vergnaud AC, Peeters PH, van Gils CH, Chan DS, Ferrari P, Romieu I, Jenab M, Slimani N, Clavel-Chapelon F, Fagherazzi G, Perquier F, Kaaks R, Teucher B, Boeing H, von Rüsten A, Tjønneland A, Olsen A, Dahm CC, Overvad K, Quirós JR, Gonzalez CA, Sánchez MJ, Navarro C, Barricarte A, Dorronsoro M, Khaw KT, Wareham NJ, Crowe FL, Key TJ, Trichopoulou A, Lagiou P, Bamia C, Masala G, Vineis P, Tumino R, Sieri S, Panico S, May AM, Bueno-de-Mesquita HB, Büchner FL, Wirfält E, Manjer J, Johansson I, Hallmans G, Skeie G, Benjaminsen Borch K, Parr CL, Riboli E, Norat T. PMID: 22592101 [PubMed - as supplied by publisher]
	HLA-DRB11501 and HLA-DQB10301 alleles are positively associated with HPV16 infection-related Kazakh esophageal squamous cell carcinoma in Xinjiang China. Cancer Immunol Immunother. Hu J, Li L, Pang L, Chen Y, Yang L, Liu C, Zhao J, Chang B, Qi Y, Liang W, Li F. PMID: 22588649 [PubMed - as supplied by publisher]
	Factors affecting survival of patients with oesophageal cancer: a study using inverse Gaussian frailty models. Singapore Med J. Ghadimi MR, Mahmoodi M, Mohammad K, Rasouli M, Zeraati H, Fotouhi A. PMID: 22584975 [PubMed - in process]
	18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data. J Nucl Med. Barber TW, Duong CP, Leong T, Bressel M, Drummond EG, Hicks RJ. PMID: 22582047 [PubMed - as supplied by publisher]
	The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy. Chin J Cancer. Guo K, Cai L, Zhang Y, Zhu JF, Rong TH, Lin P, Hao CL, Wang WP, Li Z, Zhang LJ. PMID: 22572013 [PubMed - as supplied by publisher]
	Prognostic Value of Vascular Endothelia Growth Factor Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev. Chen M, Cai E, Huang J, Yu P, Li K. PMID: 22564870 [PubMed - as supplied by publisher]
	Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer. Eur Radiol. Gillies RS, Middleton MR, Blesing C, Patel K, Warner N, Marshall RE, Maynard ND, Bradley KM, Gleeson FV. PMID: 22562089 [PubMed - as supplied by publisher]
	Relationship of zolpidem and cancer risk: a taiwanese population-based cohort study. Mayo Clin Proc. Kao CH, Sun LM, Liang JA, Chang SN, Sung FC, Muo CH. PMID: 22560522 [PubMed - in process]
	Mediastinal staging of lung cancer: novel concepts. Lancet Oncol. Tournoy KG, Keller SM, Annema JT. PMID: 22554550 [PubMed - in process]
	Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA. PMID: 22552194 [PubMed - as supplied by publisher]
	Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer. Am Surg. Fox M, Farmer R, Scoggins CR, McMasters KM, Martin RC 2nd. PMID: 22546123 [PubMed - in process]
	Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. PMID: 22543217 [PubMed - as supplied by publisher]
	Gastric conduit resection and jejunal interposition for recurrent esophageal cancer. Ann Thorac Surg. van der Sluis PC, Verhage RJ, van der Horst S, Siersema PD, Braunius WW, van Hillegersberg R. PMID: 22541212 [PubMed - in process]
	Laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. Rev Esp Enferm Dig. Maas KW, Biere SS, Scheepers JJ, Gisbertz SS, Van-der-Peet DL, Cuesta MA. PMID: 22537368 [PubMed - as supplied by publisher]
	Effectiveness of CO2-insufflated endoscopic submucosal dissection with the duodenal balloon occlusion method for early esophageal or gastric cancer: a randomized case control prospective study. BMC Gastroenterol. Mori H, Kobara H, Fujihara S, Nishiyama N, Izuishi K, Ohkubo M, Rafiq K, Suzuki Y, Masaki T. PMID: 22530773 [PubMed - as supplied by publisher]
	Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database. Cancer Causes Control. Cooper SC, Trudgill NJ. PMID: 22527175 [PubMed - in process]
	Does Obesity Affect Outcomes in Patients Undergoing Esophagectomy for Cancer? A Meta-analysis. World J Surg. Kayani B, Okabayashi K, Ashrafian H, Harling L, Rao C, Darzi A, Kitagawa Y, Athanasiou T, Zacharakis E. PMID: 22526035 [PubMed - as supplied by publisher]
	Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies. Nutr Cancer. Bosetti C, Rosato V, Polesel J, Levi F, Talamini R, Montella M, Negri E, Tavani A, Zucchetto A, Franceschi S, Corrao G, Vecchia CL. PMID: 22519904 [PubMed - as supplied by publisher]
	Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. PMID: 22517822 [PubMed - as supplied by publisher]
	Utility of Restaging Endoscopic Ultrasound After Neoadjuvant Therapy for Esophageal Cancer. Ann Thorac Surg. Griffin JM, Reed CE, Denlinger CE. PMID: 22516835 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 14034

Seite 1 von 702

Ein Expertenteam bürgt für Aktualität und Qualität. Mitglieder sind:

- Prof. Ch. Beglinger

Basel

- Prof. F. Seibold

Bern

- Prof. G. Rogler

Zürich

Literatursuche andere Fachgebiete

Fachliteratur auf medline.ch screenen und gleich online bestellen

mehr >>

Partner

Unrestricted educational grant by



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch Tel: +41 (0)44 204 16 77 Fax: +41(0)44 204 16 70
	Disclaimer \| Privacy Policy